Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
Start Date
9/25/2024
Completion Date
12/1/2026
Summary
The purpose this research is to compare two different standards of care for pain management and two different standards of care for local numbing medicine for breast cancer patients who will have a total mastectomy.
Detailed Description
The purpose this research is to compare two different standards of care for pain management and two different standards of care for local numbing medicine for breast cancer patients who will have a total mastectomy. Standard of care intervention is preoperative PECS-II blocks versus Intraoperative Pectoral Blocks. The medication used are standard of care and include Bupivacaine and liposomal bupivacaine. Bupivacaine is FDA approved and indicated for the local or regional anesthesia or analgesia for surgery procedures and therapeutic procedures. Liposomal bupivacaine is FDA approved and indicated for adults to produce postsurgical local analgesia and as nerve block to produce postsurgical regional analgesia.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Bupivacain
Exparel
Intraoperative Pecs II block (IOB) & superior AT (EX or BP)
Preoperative Pecs II block (POB) & superior AT (EX or BP)
Conditions
Locations
University of Cincinnati Medical Center
Cincinnati, Ohio 45219
United States